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Immune rejection and scarcity of donor tissues are the restrictions of islets 
transplantation. In this study, the cytoprotection of chitosan hydrogels in xenogeneic 
islet transplantation was demonstrated. Wistar rat islets encapsulated in chitosan 
hydrogels were performed glucose challenge test and live/dead cell staining in vitro. 
Islets/chitosan hydrogels were transplanted into the renal subcapsular space of 
diabetic C57BL/6 mice. Non-fasting blood glucose level (NFBG), body weight, 
intraperitoneal glucose tolerance test (IPGTT), and glucose disappearance rate were 
determined perioperatively. The serum insulin level was analyzed, and the kidney 
transplanted with islets/chitosan hydrogels were retrieved for histological examination 
after sacrifice. The present results showed that islets encapsulated in chitosan 
hydrogels secreted insulin in response to the glucose stimulation as naked islets with 
higher cell survival. The NFBG of diabetic mice transplanted with islets/chitosan 
hydrogels decreased from 487±46 to 148±32 at one day postoperation and maintained 
in the range of 201±36 mg/dl for four weeks with an increase in body weight. IPGTT 
showed the glucose disappearance rate of mice transplanted with islets/chitosan 
hydrogels was significant faster than that of mice transplanted with naked islets; the 
serum insulin level increased from 0.29±0.06 to 1.69±0.65 μg/dl postoperatively. 
Histological examination revealed that the islets successfully engrafted at renal 
subcapsular space with positive insulin staining. The immunostain was negative for 
neither the T-cell lineages nor the monocyte/macrophages. This study indicates that 
the chitosan hydrogels deliver and protect encapsulated islets successfully in 
xenotransplantation. 
 




Pancreatic islet transplantation normalizes the metabolic control of blood glucose 
to prevent the development of chronic complications is an efficacious treatment for 
type 1 diabetes [1]. Although limited donor sources prevent islet transplantation from 
becoming a major treatment option. A diabetic patient often requires two or even three 
donor pancreases to achieve successful transplantation which makes the problem of 
donor shortage even more serious [2]. Using xenogeneic species as donor sources 
may solve the problem of an insufficient donor supply [3]. However, xenogeneic 
islets are subject to immune rejection in humans because of the extensive antigenic 
differences [4]. Therefore, immune rejection still remains a major restriction to 
xenotransplantation. 
Immunoisolation is an effective approach which can facilitate the use of 
xenogeneic cell source to solve the problem of insufficient donor supply, and can 
minimize or eliminate the need of systemic immunosuppression [5]. The approach is 
utilizing a semi-permeable barrier to enclose the transplanted cells which can protect 
enclosed cells from the attack of recipient’s immune system. The enclosed cells can 
secrete therapeutic molecules and diffuse through the semi-permeable barrier to 
recipient’s body. Several immunoisolative systems have been developed that include 
islets enclosed in a semi-permeable membrane [6], diffusion chamber [7], 
microencapsulation [8] and macroencapsulation system [9]. 
Injectable hydrogels is of great interest in cell encapsulation and tissue 
engineering [10]. Chitosan based hydrogels, a thermosensitive material composing of 
chitosan and glycerol 2-phosphate disodium salt hydrate, is liquid at room 
temperature and gelation as hydrogels at 37 C [11]. The densely reticulate structure 
of hydrogels may serve as a barrier to protect encapsulated tissues. In addition, the 
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mass diffusion of small molecules within the hydrogels is fast due to the property of 
high water content [12]. Moreover, this hydrogels even has cytoprotective effect to 
against cytokine-mediated cytotoxicity [13]. These characteristics make the hydrogels 
as a promising material for immunoisolation.  
In this study, a concordant animal model was applied to evaluate the 
cytoprotection of chitosan hydrogels in xenogeneic islet transplantation. Our 
hypothesis was that islets could be protected from the attack of recipient immune 




MATERIAL AND METHOD 
Preparation of chitosan hydrogels 
2.5 % chitosan (417963, Sigma, USA) solved in 0.1 M acetic acid (017-00256, 
Wako, Japan) was autoclaved for sterilization. Glycerol 2-phosphate disodium salt 
hydrate (β-GP, G6251, Sigma, USA) solved in deionized water (0.8 W/V) was filtered 
by a 0.22 μm filter (Millex-HA, Millipore, USA) for sterilization. The β-GP solution 
was added dropwise into the chitosan solution under stirring and until the pH value of 
the mixed solution became 7.4. The chitosan/β-GP solution was preserved in a 4 C 
refrigerator before further study. 
 
Islet isolation and evaluation 
The animal experiment was reviewed and approved by the Institutional Animal 
Care and Use Committee for Frontier Medical Sciences, Kyoto University. Wistar rats 
(male, aged 9-10 weeks, Shimizu laboratory supplies, Japan) were used as donors. 
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Islet isolation was done according to methods in the previous study [14]. Briefly, 
through mid-line laparotomy, 10 ml of type XI collagenase solution (1200 CDU/ml, 
C9407, Sigma, USA) was infused into the common bile duct that legated at the 
hepatic side before the inflow to the duodenum. The pancreases were removed and 
digested in a water bath set at 37 C for 18 mins. The digested pancreases were 
filtered by stainless steel mash to separate the islets, and purified by the discontinuous 
gradient solution (Dextran 70, 17-0280-02, Amersham, Sweden). 
The purity of islet was assessed with dithizone staining (D5130, Sigma, USA) 
and >85 %. Islet quantity was determined as islet equivalents (IEQ) using a formula to 
convert islet populations of differing sizes to islet volume [15]. The yield of islet was 
700-800 IEQ per rat. The harvested islets were cultured in CRML-1066 medium 
(11530, Gibco, USA) supplemented with 1 % antibiotic-antimycotic solution 
(15240-062, Gibco, USA) and 10 % fetal bovine serum (12103-78P, JRH, USA) in a 
incubator set at 5 % CO2, 37 C.  
 
In vitro glucose challenge 
Islets suspended in chitosan/β-GP solution at the density of 500IEQ/1000μl 
solution were injected into a 24-well culture plate; each well had 200 μl of chitosan 
solution with 100 IEQ. The culture plate was placed in a 37 C incubator for 10 mins 
for gelation, and the CMRL-1066 medium was added into each well. After cultured 
for 1, 3 and 7 days, the medium was removed and the hydrogels with islets were 
washed twice by phosphate buffered saline (PBS); then 1 ml of CMRL-1066 medium 
with 3.3 mmole glucose was added and cultured for 1 hr. The medium was then 
replaced with CMRL1066 medium with 16.7 mmole glucose and further incubated for 
1 hr. Finally, the medium was replaced with CMRL-1066 medium with 3.3 mmole 
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glucose and cultured for another 1 hr. At the end of each incubation period, the media 
were collected and analyzed by rat insulin enzyme-linked immunosorbent assay (rat 
insulin ELISA assay, AKRIN-010T, Shibayagi, Japan) with a microplate reader 
(iMark
TM
, BIO-RAD, CA, USA) at the wavelength of 450 nm. The same quantity of 
IEQ without hydrogels was performed identical procedure as a control group. The 
static glucose stimulation index (SI) was calculated by dividing the insulin secretion 
from the high glucose incubation by the insulin secretion during low glucose 
incubation. 
 
Live-dead staining and live/dead cell ratio 
The islets encapsulated in chitosan hydrogels underwent live-dead staining 
(Live-Dead double staining kit, QIA76, Calbiochem, Merek, Darmstadt, Germany) to 
analyze the cell survival after being cultured for 7 days. After treatment, 
islets/chitosan hydrogels was observed with a fluorescent microscope (IX70, 
Olympus, Japan). The live/dead cell ratio was determined by dividing the number of 
live cells (green) by the sum of live (green) and dead cells (red). Six images of 
dependant islets were chosen randomly to estimate the average live/dead cell ratio. 
The control group was naked islets cultured in a 24-well culture plates for the same 
managements. 
 
Recipient preparation and transplantation 
C57BL/6 mice (Shimizu Laboratory Supplies, Japan), aged 9-10 weeks, 
weighing 23-25 g were used as recipients. Mice were induced to diabetic by single 
intraperitoneal injection of 190 mg/kg streptozotocin (S0130, Sigma, USA) solved in 
a pH=4.5 citrate buffer (09127-61, Nacalai, Japan) 14 days preoperatively. Mouse 
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with non-fasting blood glucose (NFBG) level higher than 400 mg/dl on two 
consecutive measurements was chosen as recipient. 
The animal study was divided into four groups, the first one was normal mice 
(Normal mice group, n=8); the second group was diabetic mice without any treatment 
(Diabetic mice group, n=8); the third group was diabetic mice transplanted with naked 
islets (Naked islets group, n=8); the fourth group was diabetic mice transplanted with 
chitosan/β-GP solution containing islets (Islets/hydrogels group, n=12). Diabetic mice 
induced with STZ were randomly grouped into the second, third and fourth groups. 
The operation was performed under general anesthesia of isoflurane inhalation. 
After adequate skin preparation and sterilization, a longitudinal skin incision was 
made on the lumbar dorsum of mouse, and the left kidney was exposed. For the third 
group, 500 IEQ suspended in 30 μl of PBS were transplanted into the renal 
subcapsular space. For the fourth group, 500 IEQ were suspended in 30 μl of 
chitosan/β-GP solution and transplanted. The kidney was then carefully placed back 
and the incision was closed with absorbable and non-absorbable sutures in turn. No 
immunosuppressive or anti-inflammatory therapies were treated after surgery. The 
NFBG of mice was measured by tail vein puncturing three times in the first week 
postoperatively and once a week thereafter for totally four weeks (DRI-CHEM 3000 
with GLU-W, Fujifilm, Japan). The body weights of mice were recorded 
perioperatively.  
 
Intraperitoneal glucose tolerance test 
Intraperitoneal glucose tolerance test (IPGTT) was performed after overnight 
fasting at two weeks postoperation. A glucose solution (2 g/10ml/kg body weight) 
was intraperitoneally injected to induce hyperglycemia, and the blood glucose level 
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was measured every 15 mins for the first 60 mins and every 20 mins for the following 
60 mins for totally 120 mins. Glucose disappearance rate (K value) for each group 
was calculated using the equation K=70/t1⁄2, where t1⁄2 is the time in minutes for the 
blood glucose level decrease to 50 % of its level at 15 mins [16]. 
 
Serum insulin level 
Mice were sacrificed to collect blood samples by cardiac puncturing at four 
weeks postoperation. The serum was separated for the determination of insulin with a 
rat insulin ELISA assay.  
 
Histological and immunohistochemical examination 
The kidney transplanted with naked islets or islets/chitosan hydrogels was 
removed after sacrifice for histological examination. The sections were stained with 
hematoxylin and eosin (H&E, 3008-1&3204-2, Muto, Japan). For the 
immunohistochemical staining, sections were incubated with primary anti-insulin 
antibody (monoclonal anti-rat insulin antibody, Spring bioscience, USA). The 
localization of antigen was indicated by a red color with the aminoethylcarbazole 
(AEC, Histostain-Plus kit, Invitrogen, USA). Other sections were incubated with 
primary anti-CD3 antibody (CD3
+
 T-cell lineages, monoclonal anti-mouse CD3 
antibody, eBioscience, USA) or anti-CD68 antibody (CD68
+
 monocyte/macrophages, 
monoclonal anti-mouse CD68 antibody, AbD serotec, USA) and indicated by a brown 
color with the 3, 3'-Diaminobenzidine (DAB, Histostain-Plus kit, Invitrogen, USA). 
Sections were further counter-stained with the hematoxylin and examined by optical 
microscope (BX51, Olympus, Japan). The pancreas of mouse was also harvested and 





Data was expressed as mean ± standard error of the mean (SEM). Statistical 
analyses of NFBG and body weight were analyzed by Two-way analysis of variance 
(ANOVA). In vitro glucose challenge test, live/dead cell survival, serum insulin level 
and K values of IPGTT were analyzed by One-way ANOVA. Difference was 




In vitro glucose challenge 
The results of in vitro glucose challenge are shown in Fig. 1. Insulin secretion 
increased significantly in response to the stimulation of high level glucose followed 
by decreased to basal secretion in low glucose level for both the Naked islets group 
(SI=1.99±0.49) and Islets/hydrogels group (SI=2.18±0.23) after cultured for one day. 
Naked islets group lost function to response the glucose stimulation 
progressively after cultured for 3 (SI=1.35±0.46) and 7 days (SI=1.29±0.33). The SI 
on day 3 and 7 of Naked islets group were significant lower than that of day 1 
(p<0.05). On the contrary, islets encapsulated in chitosan hydrogels maintained the 
function of insulin secretion and responded to the glucose stimulation. The static 
glucose stimulation index of Islets/hydrogels group was 2.28±0.14 for day 3 and 
1.89±0.23 for day 7, respectively; that was significant higher than that of Naked islets 
group (p<0.05). 
 
Live-dead staining and live/dead cell ratio 
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 Fig. 2 is the live-dead staining for the islets encapsulated in chitosan hydrogels. 
The cell survival ratio for islets encapsulated in hydrogels (Fig. 2(a), 84.2±4.9 %) was 
significant higher than that of naked islets (Fig. 2(b), 28.9±7.3 %) (n=6, p>0.01).  
 
Animal study 
The NFBG of Naked islets group decreased from 472±34 to 163±40 mg/dl one 
day post-operatively and maintained in the range of 160-213 mg/dl for 3 days (Fig. 
3(a)). However, it returned to 311±110 mg/dl at day 7 and restored to hyperglycemic 
status thereafter. The NFBG of Islets/hydrogels group decreased from 487±56 to 
148±32 mg/dl and maintained in the range of 148-242 mg/dl for four weeks with a 
significant difference (p<0.05) with that of Naked islets group or Diabetic mice 
group. 
The changes in body weights are shown in Fig. 3(b). The body weights of Naked 
islets group decreased from 24.3±1.4 to 18.7±1.2 g that did not has a significant 
difference with that of Diabetic mice group (p>0.05). The body weight of 
Islets/hydrogels group increased progressively from 21.8±1.3 to 24.8±1.0 g which 
was significantly higher than that of Naked mice group (p<0.01). 
  
Intraperitoneal glucose tolerance test 
Fig. 3(c) shows the blood glucose variation for the IPGTT. Mice of 
Islets/hydrogels group showed significantly lower blood glucose level when 
compared with that of Naked islets group. The K value of Normal mice group was 
0.85±0.11; that of Naked islets group could not be calculated since the blood glucose 
level did not decreased to 50% of its level at 15 mins nor the decreasing fitting line 
was not obtained in the group. The K value of Islets/hydrogels group was 0.76±0.25 
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which has no significant different with that of Normal mice group (p>0.05). 
 
Serum insulin level 
The serum insulin level of Normal mice group was 1.97±0.16 μg/dl; and that of 
Diabetic mice group has a significantly lower level (0.29±0.06 μg/dl, p<0.05, Fig. 
3(d)). The level of Naked islets group was 0.31±0.04 μg/dl which did not differ from 
that of Diabetic mice group (p>0.05). The insulin level of Islets/hydrogels group was 
1.69±0.65 μg/dl which was higher than that of Diabetic mice and Naked islets group 
significantly (p<0.01); although it was lower than the level of Normal mice group, 
there was no significant difference between them (p>0.05). 
This study was not designed to compare the mortality of each group; however, 
one mouse found dead one week post-operatively, one mouse dead at week three and 
other two mice dead at week four for Naked islets group. All mice in Islets/hydrogels 
group were survival during this study. 
 
Histological examination 
The histological sections of Islets/hydrogels group revealed that the islets grafted 
at the renal subcapsule space of mouse (Fig. 4(a), H&E, 40X). The 
immunohistochemical staining showed the islets had insulin production (Fig. 4(b), red 
color, immunostain of insulin antibody, 100X). The sections stained for CD3 or CD68 
antibody show no evidence of immune cell infiltration or accumulation (Fig. 4(c), 
immunostain of CD3 antibody, 40X; Fig. 4(d), immunostain of CD68 antibody, 
100X). Pancreases harvested from the diabetic mice contained shrunken islets with a 
decreased number of islets per section. Most islets were dissociated from the 






The cytoprotection of chitosan hydrogels for xenogeneic islet transplantation is 
demonstrated in this study. Insulin secretion of islets encapsulated in chitosan 
hydrogels was tested first. Islets encapsulated in chitosan hydrogels sensitized the 
glucose stimulation and secreted insulin to response as naked islets at day one. The 
insulin content of Islets/hydrogels group was similar to that of Naked islets group. 
This result indicates the insulin secreting function of islets was not influenced by the 
chitosan hydrogels. Islets encapsulated in hydrogels still maintained the insulin 
secreting at day 3 and 7; however, the naked islets lost function gradually. The lost of 
secreting function can be contributed to that islets require extracellular matrix for 
survival and function, and this matrix is destroyed during the isolation procedure. 
Therefore, the hydrogels serves as an extracellular matrix that potentially increases 
islet survival and function [17]. This assumption is further proved by the results of 
live/dead ratio that reveals islets encapsulated in hydrogels had higher survival.  
Regarding the results of the animal study, the NFBG of mice decreased to 
euglycemia and maintained for 7 days after naked islet transplantation. However, it 
returned to hyperglycemia which attributed to the rejection of grafts [18]. The NFBG 
of mice transplanted with islets/hydrogels also decreased to euglycemia one day 
postoperatively indicating the transplanted islets within hydrogels quickly released 
insulin into diabetic mice. Euglycemia was maintained for four weeks proving the 
continuous function of transplanted islets. Concerning the naked islets rejected within 
one week, these results indicate that chitosan hydrogels protects islets from the 
recipient’s immune system efficaciously.  
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Body weight is a common indicator for type 1 diabetes [19]. The body weight of 
diabetic mice transplanted with islets/chitosan hydrogels increased gradually. On the 
contrary, the mice transplanted with naked islets lost weight continuously in a similar 
fashion to that of the diabetic mice. Increased body weight indicates recovery of the 
blood glucose metabolism of diabetic mice, through it still lower than normal mice. 
The K value of glucose disappearance rate can be considered as an indicator to 
monitor the function of transplanted islets [20]. K value for the Islets/hydrogels group 
was much better than that of Naked islets group, and similar to the Normal mice 
group without a significant difference. These results suggest that the function of 
transplanted islets/hydrogel was comparable with native pancreatic islets. 
The sustaining insulin secretion of transplanted islets/hydrogels was further 
confirmed by the detection of serum insulin. The serum insulin level of mice 
decreased significantly after injection of STZ that reveals the native islets were 
destroyed completely. The diabetic mice transplanted with naked islets also had 
similar insulin level that reveals the transplanted islets lost its function at this time 
point. The serum insulin level of diabetic mice transplanted with islets/hydrogels 
increased significantly that means transplanted islets compensated for the native 
pancreatic islets and the insulin level was comparable with normal mice. 
In this study, STZ-induced diabetic mice had high mortality (4/8, 50 %) that was 
also reported in other experiences [21]. The mortality of Naked islets group was 50 % 
(4/8), which was higher than that of Islets/chitosan hydrogels group (0 %, 0/12). This 
finding might indicate that hydrogels protected islets effectively to improve the 
metabolism of severe diabetics that can cause about 50% mortality. All of above 
results shall be attributed to the transplanted islets in hydrogels releasing insulin 
continually to compensate the endocrine dysfunction of the pancreas in diabetic mice.  
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The histological sections reveal that the islets grafted at the renal subcapsular 
space; the transplanted islets were well-granulated with insulin production indicating 
the viability and maintained function of the transplanted islets. The immunostain was 
negative for neither the T-cell lineages (CD3
+
) nor the monocyte/macrophages 
(CD68
+
), two common infiltrating cells for implantable biomaterials [22]. This 
cytoprotection of chitosan hydrogels may attribute to the glycerol moieties in β-GP 
have positive charges which may interfere with infiltrating cells [23]. Another 
possible mechanism is the interactions of chitosan-chitosan hydrophobic which 
expected to play a major role in the gelation process, the hydrophobic property of 
chitosan hydrogels may also against infiltrating cells [24]. 
Although several kinds of gels are applied in cell encapsulation, such as agarose, 
alginate, PVA and some derivatives, chitosan gel with the thermosensitive property is 
an injectable carrier. In spite of encapsulated islets may suspend in an isotonic 
solution and inject into animal’s body, the chitosan hydrogels with proper viscosity 
shall facilitate the manipulation. In addition, it’s easier to remove the islet/chitosan 
hydrogels when compared with the microencapsulated islets since the microspheres 
may disperse widely and difficult to be retrieved. Furthermore, compared with the 
implantable BAPs such as membrane forms or diffusion chambers, the injectable 
islets/chitosan solution could be transplanted with a minimal invasive surgery under 
fluoroscopic guidance. Since the chitosan is a well-known and safe biomaterial, this 
hydrogels could be an alternative for immunoisolation in the autoimmune animal 
models, large mammals and, eventually, could be applied safely for clinical 
application. Further studies, such as the longevity of transplanted islets and a 
discordant animal model, should be demonstrated to ensure the application is suitable 






Islets encapsulated chitosan hydrogels responded glucose stimulation to secrete 
insulin as naked islets. The NFBG of diabetic mice transplanted with islets/chitosan 
hydrogels decreased to euglycemia with a progressive increased in body weight. The 
performances of transplanted islets extended from 7 days to four weeks when chitosan 
hydrogels applied. IPGTT shows that the glucose disappearance rate of mice 
transplanted with islets/chitosan hydrogels was faster than that transplanted with 
naked islets, the serum insulin level also increased postoperatively. Histological 
sections reveal the islets grafted at renal subcapsular space with positive insulin 
staining; the immunostain was negative for neither the T-cell lineages nor the 
monocyte/macrophages. This study indicates that the chitosan hydrogels deliver and 
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Fig. 1(a) Insulin secretion increased significantly in response to the stimulation of 
high level glucose followed by decreased to basal secretion in low glucose level for 
both the Naked islets group (SI=1.99±0.49) and Islets/hydrogels group (SI=2.18±0.23) 
after cultured for one day. (b) Naked islets lost function to response the glucose 
stimulation at day 3 (SI=1.35±0.46) and (c) 7 days (SI=1.29±0.33). Islets 
encapsulated in chitosan hydrogels maintained the function of insulin secretion and 
responded to the glucose stimulation during this test.  
 
Fig. 2 The green color represents live cell and the red color represents dead cell. The 
cell survival ratio for (a) islets encapsulated in hydrogels was higher than that of (b) 
naked islets.  
 
Fig. 3(a) The NFGB of Islets/chitosan hydrogels group was lower than that of 
Diabetic mice group and Naked islets group significantly; and (b) body weights of 
Islets/chitosan hydrogels group was significantly higher than that of Diabetic mice 
group and Naked islets group. (c) The IPGTT test showed that the K value of Normal 
mice group was 0.85±0.11; that of Naked islets group could not be calculated. The K 
value for Islets/hydrogels group was 0.76±0.25 that has no significant different with 
that of Normal mice group (p>0.05). (d) The serum insulin level Diabetic mice group 
was lower than that of Normal mice group significantly (p<0.01). The level of 
Islets/hydrogels group was significantly higher than Naked islets group (p<0.01), and 
no significant difference with Normal nice group(p>0.05). 
 
Fig. 4 The histologic sections of Islets/hydrogels group reveal that (a) the islets were 
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grafted at the renal subcapsule space of mouse (H&E, 40X). (b) 
Immunohistochemical staining shows the islets had positive insulin staining (red 
color, immunostain of insulin, 100X). Sections stained with antibody specific to 
immune cells show there was no immune cell infiltration or accumulation. (c) 
Negative of CD3
+ 
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